Medical weight loss that starts with 61 lab markers, not a questionnaire.

That is a clinical determination, and it is the actual purpose of the assessment. Clinicians generally consider factors including BMI, weight-related health conditions, your medical and family history, current medications, and lab findings. Some people are clearly appropriate candidates. Some have a thyroid, sleep, or medication issue that should be addressed first. Some should not take these medications at all. We will tell you which of those you are, in plain language, at the visit.

The honest answer is that it varies widely and nobody can promise you a number. What we can point to is published trial data: in STEP 1 (NEJM, 2021) adults on semaglutide 2.4 mg lost an average of about 15% of body weight over 68 weeks, and in SURMOUNT-1 (NEJM, 2022) adults on tirzepatide 15 mg lost an average of about 21% over 72 weeks. Both trials paired the medication with lifestyle intervention for every participant.

Those are averages across thousands of people. Your result depends on your starting physiology, the dose you tolerate, your protein and training habits, your sleep, and how long you stay on therapy. Individual results vary, and we will not quote you a target number to get you in the door.

For patients who qualify after their evaluation, we prescribe compounded semaglutide or tirzepatide, prepared by a licensed compounding pharmacy. We do not dispense brand-name products.

Compounded medications are not FDA-approved. The FDA does not review compounded preparations for safety, effectiveness, or manufacturing quality, and they are not rated as therapeutically equivalent to any brand-name product. Your prescriber will tell you exactly what is being prescribed, which pharmacy it comes from, the dosing schedule, the risks, and the cost before you start, and whether a compounded preparation is clinically appropriate for you at all.

The Alpha Performance Assessment is $497, paid at your visit. Nothing is due to book. The optional WatchPAT ONE home sleep study is an additional $297, paid on a follow-up call before the device ships.

We are a cash-pay practice and do not bill insurance. We provide itemized receipts suitable for HSA and FSA submission. Medication, if prescribed, is billed separately by your pharmacy; coverage for weight-management medication varies significantly by plan and many plans exclude it.

You don't need them to lose weight. You need them to know why it has been hard, whether a medication is safe for you, and what will happen when you come off it. Undiagnosed hypothyroidism, insulin resistance, low testosterone, anemia, vitamin D deficiency, and untreated sleep apnea all affect energy, appetite, training capacity, and body composition, and all of them are findable in a morning.

It also gives you a real baseline. When we repeat markers later, you can see what changed beyond the scale, including whether you are holding onto lean mass.

There is no universal answer, and any clinic that gives you one is guessing. Some people use a GLP-1 for a defined period and transition off with a structured taper. Others, particularly those with weight-related metabolic conditions, may be on therapy longer under continued clinical supervision.

What the evidence does show clearly is that weight regain after stopping is common. That is precisely why the clinical protocol we build with you covers protein intake, resistance training, sleep, and follow-up labs, the maintenance phase is discussed before you start, not after.

Our clinicians are licensed in Illinois, and we care for patients located in Illinois. We are not able to treat patients outside the state.

The assessment itself is performed at our Hinsdale office, and that is by design: the blood draw, the on-site same-day lab processing, body composition on the InBody 970 and grip strength all require you to be in the building. If you are in Illinois but a long drive from Hinsdale, call us first and we will walk you through exactly what the visit involves before you commit to a time.

It is optional. It is also, for a lot of patients, the most useful $297 they spend. Obstructive sleep apnea is common in adults carrying excess weight and frequently goes undiagnosed for years. Untreated, it is associated with poorer metabolic health, daytime fatigue, and reduced training capacity, all of which work against a weight-management plan.

The WatchPAT ONE is a single-night, at-home, FDA-cleared device. Results are typically available within 24 hours and are interpreted alongside your labs. A home sleep test is a screening tool; your clinician may still recommend an in-lab study depending on findings.

No. Purchasing or completing an assessment does not guarantee that you will receive a prescription, medication, or any particular treatment. All treatment decisions are made independently by the treating clinician based on your medical history, evaluation, diagnostic findings, clinical judgment, and applicable standards of care. If a medication is not appropriate for you, we will say so and tell you what we would do instead.